ES2657382T5 - Células madre mesenquimales y usos de las mismas - Google Patents

Células madre mesenquimales y usos de las mismas Download PDF

Info

Publication number
ES2657382T5
ES2657382T5 ES14172807T ES14172807T ES2657382T5 ES 2657382 T5 ES2657382 T5 ES 2657382T5 ES 14172807 T ES14172807 T ES 14172807T ES 14172807 T ES14172807 T ES 14172807T ES 2657382 T5 ES2657382 T5 ES 2657382T5
Authority
ES
Spain
Prior art keywords
mesenchymal stem
cells
stem cells
mscs
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES14172807T
Other languages
English (en)
Spanish (es)
Other versions
ES2657382T3 (es
Inventor
Mark F Pittenger
Sudeepta Aggarwal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mesoblast International SARL
Original Assignee
Mesoblast International SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mesoblast International SARL filed Critical Mesoblast International SARL
Publication of ES2657382T3 publication Critical patent/ES2657382T3/es
Application granted granted Critical
Publication of ES2657382T5 publication Critical patent/ES2657382T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • C12N5/0663Bone marrow mesenchymal stem cells (BM-MSC)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES14172807T 2004-03-22 2005-03-15 Células madre mesenquimales y usos de las mismas Expired - Lifetime ES2657382T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55511804P 2004-03-22 2004-03-22
US555118P 2004-03-22

Publications (2)

Publication Number Publication Date
ES2657382T3 ES2657382T3 (es) 2018-03-05
ES2657382T5 true ES2657382T5 (es) 2021-07-12

Family

ID=46060822

Family Applications (7)

Application Number Title Priority Date Filing Date
ES14172807T Expired - Lifetime ES2657382T5 (es) 2004-03-22 2005-03-15 Células madre mesenquimales y usos de las mismas
ES10011224.2T Expired - Lifetime ES2643076T3 (es) 2004-03-22 2005-03-15 Células madre mesenquimales y sus usos
ES10011225.9T Expired - Lifetime ES2544689T3 (es) 2004-03-22 2005-03-15 Células madre mesenquimales y usos de las mismas
ES14172800T Expired - Lifetime ES2708627T3 (es) 2004-03-22 2005-03-15 Células madre mesenquimales y sus usos
ES10011226.7T Expired - Lifetime ES2645018T3 (es) 2004-03-22 2005-03-15 Células madre mesenquimales y usos para estas
ES10011223.4T Expired - Lifetime ES2643030T3 (es) 2004-03-22 2005-03-15 Células madre mesenquimales y sus usos
ES05725577T Expired - Lifetime ES2385450T3 (es) 2004-03-22 2005-03-15 Células madre mesenquimatosas y sus utilizaciones

Family Applications After (6)

Application Number Title Priority Date Filing Date
ES10011224.2T Expired - Lifetime ES2643076T3 (es) 2004-03-22 2005-03-15 Células madre mesenquimales y sus usos
ES10011225.9T Expired - Lifetime ES2544689T3 (es) 2004-03-22 2005-03-15 Células madre mesenquimales y usos de las mismas
ES14172800T Expired - Lifetime ES2708627T3 (es) 2004-03-22 2005-03-15 Células madre mesenquimales y sus usos
ES10011226.7T Expired - Lifetime ES2645018T3 (es) 2004-03-22 2005-03-15 Células madre mesenquimales y usos para estas
ES10011223.4T Expired - Lifetime ES2643030T3 (es) 2004-03-22 2005-03-15 Células madre mesenquimales y sus usos
ES05725577T Expired - Lifetime ES2385450T3 (es) 2004-03-22 2005-03-15 Células madre mesenquimatosas y sus utilizaciones

Country Status (5)

Country Link
JP (8) JP6114500B2 (enExample)
AT (1) ATE556134T1 (enExample)
CA (3) CA2868733C (enExample)
ES (7) ES2657382T5 (enExample)
TR (1) TR201901268T4 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201901268T4 (tr) * 2004-03-22 2019-02-21 Mesoblast Int Sarl Mezenkimal kök hücreleri ve bunların kullanımları.
EP2298863B1 (en) * 2004-03-22 2015-07-22 Mesoblast International Sàrl Mesenchymal stem cells and uses therefor
WO2014098960A2 (en) * 2012-05-16 2014-06-26 The Johns Hopkins University Stem cells as an individualized maternal therapy for prevention of prematurity
JP2016210730A (ja) * 2015-05-08 2016-12-15 上田 実 医薬組成物及びその製造方法並びに医薬品
WO2018092769A1 (ja) 2016-11-15 2018-05-24 株式会社カネカ 胎児付属物に由来する間葉系幹細胞を含む細胞集団とその製造方法、及び医薬組成物
WO2019102268A1 (en) 2017-11-22 2019-05-31 Mesoblast International Sarl Cellular compositions and methods of treatment i
JP7454379B2 (ja) 2017-12-28 2024-03-22 株式会社カネカ 接着性幹細胞を含む細胞集団とその製造方法、及び医薬組成物
JP7530893B2 (ja) 2019-06-14 2024-08-08 株式会社カネカ 間葉系細胞を含む細胞集団、それを含む医薬組成物、及び、その製造方法
AU2020330745A1 (en) * 2019-08-15 2022-03-24 Nextcell Pharma Ab Allogeneic composition for treatment of CNS disorders
CN113813288B (zh) * 2021-08-11 2024-02-13 谢岩 间充质干细胞及包含其的组合物用于制备治疗烧伤难愈创面的药物的用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0651641B2 (ja) * 1983-08-29 1994-07-06 株式会社ミドリ十字 ガンマ・インターフェロン組成物
JPH01501792A (ja) * 1986-03-17 1989-06-22 シェリング・コーポレーション γ型インターフェロンによる癌の治療
JPH10501815A (ja) * 1994-06-07 1998-02-17 リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミネソタ 抗原特異的t細胞応答の阻害方法
AU2808397A (en) * 1996-04-26 1997-11-19 Case Western Reserve University Skin regeneration using mesenchymal stem cells
US6368636B1 (en) * 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
US6328960B1 (en) * 1998-03-18 2001-12-11 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
DE69910362T2 (de) * 1998-04-03 2004-06-24 Osiris Therapeutics, Inc. Anwendung der mesenchymalen stammzellen als immunsuppressiva
CA2397919A1 (en) * 2000-01-19 2001-07-26 Parkash S. Gill Pharmaceutical compositions and methods of treatment based on vegf antisense oligonucleotides
DE60143517D1 (de) * 2000-04-25 2011-01-05 Osiris Therapeutics Inc Wiederherstellung der gelenken mit mesenchymalen stammzellen
ES2399503T5 (es) * 2002-02-01 2021-04-08 Merck Sharp & Dohme Uso de reactivos relacionados con citocinas de mamíferos
JP3897343B2 (ja) * 2002-08-01 2007-03-22 株式会社林原生物化学研究所 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質
JP4672370B2 (ja) * 2002-12-05 2011-04-20 ケース ウエスタン リザーブ ユニバーシティ 虚血の細胞ベースの治療
TR201901268T4 (tr) * 2004-03-22 2019-02-21 Mesoblast Int Sarl Mezenkimal kök hücreleri ve bunların kullanımları.
EP2298863B1 (en) * 2004-03-22 2015-07-22 Mesoblast International Sàrl Mesenchymal stem cells and uses therefor

Also Published As

Publication number Publication date
CA2934682A1 (en) 2005-10-06
CA2868733C (en) 2019-12-17
ES2544689T3 (es) 2015-09-02
ES2645018T3 (es) 2017-12-01
ATE556134T1 (de) 2012-05-15
ES2657382T3 (es) 2018-03-05
CA2934682C (en) 2021-12-07
JP6757383B2 (ja) 2020-09-16
JP2018009002A (ja) 2018-01-18
JP2019014747A (ja) 2019-01-31
HK1205677A1 (en) 2015-12-24
ES2385450T3 (es) 2012-07-25
JP6382360B2 (ja) 2018-08-29
TR201901268T4 (tr) 2019-02-21
JP2015061862A (ja) 2015-04-02
CA2868733A1 (en) 2005-10-06
JP7033159B2 (ja) 2022-03-09
CA3135582A1 (en) 2005-10-06
JP5997237B2 (ja) 2016-09-28
HK1205531A1 (en) 2015-12-18
JP2021191771A (ja) 2021-12-16
JP2023065486A (ja) 2023-05-12
ES2643076T3 (es) 2017-11-21
JP6757300B2 (ja) 2020-09-16
ES2643030T3 (es) 2017-11-21
ES2708627T3 (es) 2019-04-10
JP2020111591A (ja) 2020-07-27
JP7546239B2 (ja) 2024-09-06
JP2012176948A (ja) 2012-09-13
JP2017080507A (ja) 2017-05-18
JP6114500B2 (ja) 2017-04-12

Similar Documents

Publication Publication Date Title
EP2824175B1 (en) Mesenchymal stem cells and uses therefor
ES2765650T3 (es) Células madre mesenquimales para su uso en el mejoramiento de la función pulmonar
ES2657382T5 (es) Células madre mesenquimales y usos de las mismas
AU2012205269B2 (en) Mesenchymal stem cells and uses therefor
KR20210138808A (ko) 중간엽 줄기 세포 및 그에 대한 용도
AU2020201636B2 (en) Mesenchymal stem cells and uses therefor
ES2577703T3 (es) Células madre mesenquimales para su uso en el tratamiento de una enfermedad pulmonar
HK1262056A1 (en) Mesenchymal stem cells and uses therefor
HK1205677B (en) Mesenchymal stem cells and uses therefor
HK1205531B (en) Mesenchymal stem cells and uses therefor